Ngā hua rapu - Man‐Fung Yuen

Whakamahine hua
  1. 1
    Treatment of chronic hepatitis B: Evolution over two decades

    Treatment of chronic hepatitis B: Evolution over two decades mā Man‐Fung Yuen, Ching‐Lung Lai

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Chronic Hepatitis B — New Goals, New Treatment

    Chronic Hepatitis B — New Goals, New Treatment mā Ching‐Lung Lai, Man‐Fung Yuen

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Hepatocellular carcinoma in the Asia pacific region

    Hepatocellular carcinoma in the Asia pacific region mā Man‐Fung Yuen, Jinlin Hou, Anuchit Chutaputti

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Hepatitis B and C virus-related carcinogenesis

    Hepatitis B and C virus-related carcinogenesis mā James Fung, Ching‐Lung Lai, Man‐Fung Yuen

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Natural history of hepatitis-related hepatocellular carcinoma

    Natural history of hepatitis-related hepatocellular carcinoma mā David Yiu‐Kuen But, Ching‐Lung Lai, Man‐Fung Yuen

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Acute‐on‐chronic liver failure in chronic hepatitis B

    Acute‐on‐chronic liver failure in chronic hepatitis B mā Wai‐Kay Seto, Ching‐Lung Lai, Man‐Fung Yuen

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Letter regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”

    Letter regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement” mā Lung‐Yi Mak, Man‐Fung Yuen, Wai‐Kay Seto

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis <scp>B</scp> treatment

    Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis <scp>B</scp> treatment mā James Fung, Wai‐Kay Seto, Ching‐Lung Lai, Man‐Fung Yuen

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives

    Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives mā Beom Kyung Kim, James Fung, Man‐Fung Yuen, Seung Up Kim

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B

    Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B mā James Fung, Ching‐Lung Lai, Wai‐Kay Seto, Man‐Fung Yuen

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region

    Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region mā Ran Zhu, Wai‐Kay Seto, Ching‐Lung Lai, Man‐Fung Yuen

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    New Biomarkers of Chronic Hepatitis B

    New Biomarkers of Chronic Hepatitis B mā Lung‐Yi Mak, Wai‐Kay Seto, James Fung, Man‐Fung Yuen

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Screening strategy for non-alcoholic fatty liver disease

    Screening strategy for non-alcoholic fatty liver disease mā Saisai Zhang, Lung‐Yi Mak, Man‐Fung Yuen, Wai‐Kay Seto

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Hepatocellular carcinoma: recent advances and emerging medical therapies

    Hepatocellular carcinoma: recent advances and emerging medical therapies mā Kwan‐Lung Ko, Lung‐Yi Mak, Ka Shing Cheung, Man‐Fung Yuen

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    RNA interference as a novel treatment strategy for chronic hepatitis B infection

    RNA interference as a novel treatment strategy for chronic hepatitis B infection mā Rex Wan‐Hin Hui, Lung‐Yi Mak, Wai‐Kay Seto, Man‐Fung Yuen

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    One-Year Entecavir or Lamivudine Therapy Results in Reduction of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA Levels

    One-Year Entecavir or Lamivudine Therapy Results in Reduction of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA Levels mā Danny Ka‐Ho Wong, Man‐Fung Yuen, Vincent Ngai, James Fung, Ching‐Lung Lai

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong

    Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong mā TT Cheung, Ching‐Lung Lai, Benjamin C.Y. Wong, James Fung, Man‐Fung Yuen

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015

    Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015 mā Ka Shing Cheung, Wai‐Kay Seto, James Fung, Ching‐Lung Lai, Man‐Fung Yuen

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1‐year prospective study

    Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1‐year prospective study mā Man‐Fung Yuen, S. Tam, J. Fung, David Wong, Benjamin C.Y. Wong, Ching‐Lung Lai

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities

    Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities mā P. M. Lam, Fan Cheung, Hor‐Yue Tan, Ning Wang, Man‐Fung Yuen, Yibin Feng

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: